127 related articles for article (PubMed ID: 28688842)
21. Design of prolonged release tablets using new solid acrylic excipients for direct compression.
Villanova JC; Ayres E; Oréfice RL
Eur J Pharm Biopharm; 2011 Nov; 79(3):664-73. PubMed ID: 21827852
[TBL] [Abstract][Full Text] [Related]
22. Development of novel diclofenac potassium controlled release tablets by wet granulation technique and the effect of co-excipients on in vitro drug release rates.
Shah S; Khan GM; Jan SU; Shah K; Hussain A; Khan H; Khan H; Khan H; Khan KA
Pak J Pharm Sci; 2012 Jan; 25(1):161-8. PubMed ID: 22186325
[TBL] [Abstract][Full Text] [Related]
23. Role of surfactant and pH on dissolution properties of fenofibrate and glipizide--a technical note.
Jamzad S; Fassihi R
AAPS PharmSciTech; 2006 Apr; 7(2):E33. PubMed ID: 16796351
[TBL] [Abstract][Full Text] [Related]
24. Three-Dimensional (3D)-Printed Zero-Order Released Platform: a Novel Method of Personalized Dosage Form Design and Manufacturing.
Fang D; Yang Y; Cui M; Pan H; Wang L; Li P; Wu W; Qiao S; Pan W
AAPS PharmSciTech; 2021 Jan; 22(1):37. PubMed ID: 33409925
[TBL] [Abstract][Full Text] [Related]
25. Microwave-generated bionanocomposites for solubility and dissolution enhancement of poorly water-soluble drug glipizide: in-vitro and in-vivo studies.
Kushare SS; Gattani SG
J Pharm Pharmacol; 2013 Jan; 65(1):79-93. PubMed ID: 23215691
[TBL] [Abstract][Full Text] [Related]
26. Egg shell membrane as a substrate for optimizing in vitro transbuccal delivery of glipizide.
Philip AK; Singh N; Pathak K
Pharm Dev Technol; 2009; 14(5):540-7. PubMed ID: 19552562
[TBL] [Abstract][Full Text] [Related]
27. Formulation and optimization of osmotically controlled release tablets of glipizide: hot melt granulation.
Panda RR; Tiwary AK
Ther Deliv; 2010 Dec; 1(6):763-74. PubMed ID: 22834012
[TBL] [Abstract][Full Text] [Related]
28. Formulation study and drug release mechanism of a new theophylline sustained-release preparation.
Hayashi T; Kanbe H; Okada M; Suzuki M; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
Int J Pharm; 2005 Nov; 304(1-2):91-101. PubMed ID: 16154302
[TBL] [Abstract][Full Text] [Related]
29. Effect of formulation parameters on the drug release and floating properties of gastric floating two-layer tablets with acetylsalicylic acid.
Hasçiçek C; Yüksel-Tilkan G; Türkmen B; Ozdemir N
Acta Pharm; 2011 Sep; 61(3):303-12. PubMed ID: 21945909
[TBL] [Abstract][Full Text] [Related]
30. Extended release dosage form of glipizide: development and validation of a level A in vitro-in vivo correlation.
Ghosh A; Bhaumik UK; Bose A; Mandal U; Gowda V; Chatterjee B; Chakrabarty US; Pal TK
Biol Pharm Bull; 2008 Oct; 31(10):1946-51. PubMed ID: 18827360
[TBL] [Abstract][Full Text] [Related]
31. Influence of beta-cyclodextrin complexation on glipizide release from hydroxypropyl methylcellulose matrix tablets.
Shivakumar HN; Desai BG; Pandya S; Karki SS
PDA J Pharm Sci Technol; 2007; 61(6):472-91. PubMed ID: 18410048
[TBL] [Abstract][Full Text] [Related]
32. Inlay osmotic pump tablets containing metformin and glipizide.
Patel RB; Patel GN; Patel HR; Patel MM
Drug Dev Ind Pharm; 2011 Oct; 37(10):1244-52. PubMed ID: 21466414
[TBL] [Abstract][Full Text] [Related]
33. Gamma scintigraphic study of the hydrodynamically balanced matrix tablets of Metformin HCl in rabbits.
Razavi M; Karimian H; Yeong CH; Sarji SA; Chung LY; Nyamathulla S; Noordin MI
Drug Des Devel Ther; 2015; 9():3125-39. PubMed ID: 26124637
[TBL] [Abstract][Full Text] [Related]
34. Graft copolymers of ethyl methacrylate on waxy maize starch derivatives as novel excipients for matrix tablets: drug release and fronts movement kinetics.
Marinich JA; Ferrero C; Jiménez-Castellanos MR
Eur J Pharm Biopharm; 2012 Apr; 80(3):674-81. PubMed ID: 22210473
[TBL] [Abstract][Full Text] [Related]
35. Compression-coated tablets of glipizide using hydroxypropylcellulose for zero-order release: in vitro and in vivo evaluation.
Huang H; Wu Z; Qi X; Zhang H; Chen Q; Xing J; Chen H; Rui Y
Int J Pharm; 2013 Mar; 446(1-2):211-8. PubMed ID: 23370433
[TBL] [Abstract][Full Text] [Related]
36. Two- and three-layer tablet drug delivery systems for oral sustained release of soluble and poorly soluble drugs.
Efentakis M; Naseef H; Vlachou M
Drug Dev Ind Pharm; 2010 Aug; 36(8):903-16. PubMed ID: 20196641
[TBL] [Abstract][Full Text] [Related]
37. Formulation of controlled-release baclofen matrix tablets: influence of some hydrophilic polymers on the release rate and in vitro evaluation.
Abdelkader H; Abdalla OY; Salem H
AAPS PharmSciTech; 2007 Nov; 8(4):E100. PubMed ID: 18181521
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of bioadhesive glipizide spheres and compacts from spheres prepared by extruder/marumerizer technique.
Garcia J; Ghaly ES
Pharm Dev Technol; 2001 Aug; 6(3):407-17. PubMed ID: 11485182
[TBL] [Abstract][Full Text] [Related]
39. Development of a controlled release low dose class II drug-Glipizide.
Jamzad S; Fassihi R
Int J Pharm; 2006 Apr; 312(1-2):24-32. PubMed ID: 16481135
[TBL] [Abstract][Full Text] [Related]
40. In vitro and in vivo evaluation of two extended release preparations of combination metformin and glipizide.
Defang O; Shufang N; Wei L; Hong G; Hui L; Weisan P
Drug Dev Ind Pharm; 2005 Aug; 31(7):677-85. PubMed ID: 16207615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
